Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, and hemostasis. Talecris is proudly building upon a 60-year legacy of innovation and a commitment to improving the lives of people who rely on its therapeutic products. With an emphasis on scientific inquiry and technological excellence, Talecris is expanding its current portfolio of products, programs, and services through its own world-class product development organization as well as through strategic initiatives that leverage its strengths with those of its partners.

Talecris, which earns revenues of over $1 billion per year, is headquartered in biotech hub Research Triangle Park, N.C., and employs more than 4,000 talented people worldwide.

To learn more about Talecris and how our employees are making a difference in the lives of patients and the healthcare community, visit www.talecris.com

Talecris links

• Talecris Global
• Career Opportunities

• General Conditions of Use
• Privacy Statement
• Imprint

The program was launched in 2006, with seven awards granted in 2007 and five in 2008 (see Previous Awardees section for more details). Letters of Intent (LOI) for the next round of awards are due by  August 1, 2008. Disbursements of grants will begin early in January 2009.

This Web site will guide you through all aspects of the Talents Program including the goals of the program and how to apply. If you require additional information, please contact the Program Administrator at: talents@porterhouse.biz.